Fmr LLC Has $502.36 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

FMR LLC lifted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 37.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,409,313 shares of the company's stock after purchasing an additional 2,571,580 shares during the quarter. FMR LLC owned about 5.04% of Doximity worth $502,363,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Arrowstreet Capital Limited Partnership increased its position in shares of Doximity by 708.7% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,510,416 shares of the company's stock valued at $80,641,000 after purchasing an additional 1,323,634 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Doximity by 1,178.3% during the fourth quarter. Franklin Resources Inc. now owns 1,062,211 shares of the company's stock worth $56,711,000 after purchasing an additional 979,113 shares during the last quarter. Lord Abbett & CO. LLC purchased a new stake in shares of Doximity in the 3rd quarter valued at about $29,453,000. Wilmington Savings Fund Society FSB purchased a new position in Doximity during the 3rd quarter worth approximately $24,691,000. Finally, Vanguard Group Inc. increased its position in Doximity by 4.5% during the fourth quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock worth $598,159,000 after buying an additional 485,102 shares during the period. Hedge funds and other institutional investors own 87.19% of the company's stock.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. The trade was a 75.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 37.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

DOCS has been the topic of a number of recent research reports. Raymond James restated an "outperform" rating and issued a $83.00 price objective (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Canaccord Genuity Group boosted their price objective on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a report on Friday, February 7th. Leerink Partnrs raised Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Stephens began coverage on Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 target price on the stock. Finally, Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $64.72.

Doximity Trading Up 1.3 %

NASDAQ:DOCS traded up $0.67 during mid-day trading on Tuesday, reaching $53.27. 528,112 shares of the stock were exchanged, compared to its average volume of 1,974,595. The firm has a market capitalization of $9.94 billion, a PE ratio of 53.25, a PEG ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21. The business has a fifty day moving average price of $64.63 and a 200 day moving average price of $55.65.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.